NEW YORK (GenomeWeb News) – DNage, a wholly owned subsidiary of Dutch biotech Pharming Group, said today that it will participate in a five-year European study that aims to identify biomarkers of human aging.
The project, called MARK-AGE, is an EU-wide consortium of 26 industry and academic partners funded under the Seventh Research Framework Program. The EU has awarded a total of around €12 million ($19 million) for the study. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.